Historial de carrera de Kristie Wagner
Antiguos cargos conocidos de Kristie Wagner.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/11/2013 | 01/02/2021 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Comptroller/Controller/Auditor | 01/06/2021 | - |
| Director Financiero/CFO | 24/02/2022 | - |
Formación de Kristie Wagner.
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kristie Wagner
- Experiencia
